Cargando…
Liver Iron Load Influences Hepatic Fat Fraction in End-Stage Renal Disease Patients on Dialysis: A Proof of Concept Study
BACKGROUND: Nonalcoholic fatty liver disease (NAFLD) is a spectrum of diseases including steatosis, nonalcoholic steatohepatitis (NASH), cirrhosis, and end-stage liver failure. Hepatic iron accumulation has been linked to hepatic fibrosis severity in NASH and NAFLD. Iron overload induced by parenter...
Autores principales: | Rostoker, Guy, Loridon, Christelle, Griuncelli, Mireille, Rabaté, Clémentine, Lepeytre, Fanny, Ureña-Torres, Pablo, Issad, Belkacem, Ghali, Nasredine, Cohen, Yves |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6354439/ https://www.ncbi.nlm.nih.gov/pubmed/30502056 http://dx.doi.org/10.1016/j.ebiom.2018.11.020 |
Ejemplares similares
-
Histological Scores Validate the Accuracy of Hepatic Iron Load Measured by Signal Intensity Ratio and R2* Relaxometry MRI in Dialysis Patients
por: Rostoker, Guy, et al.
Publicado: (2019) -
Analysis of liver iron concentration in an elderly female undergoing hemodialysis with calcific uremic arteriolopathy does not support the role of iron overload in calciphylaxis: lesson for the clinical nephrologist
por: Rostoker, Guy, et al.
Publicado: (2021) -
Hepatic Iron Load at Magnetic Resonance Imaging Is Normal in Most Patients Receiving Peritoneal Dialysis
por: Issad, Belkacem, et al.
Publicado: (2017) -
Differential Pharmacokinetics of Liver Tropism for Iron Sucrose, Ferric Carboxymaltose, and Iron Isomaltoside: A Clue to Their Safety for Dialysis Patients
por: Rostoker, Guy, et al.
Publicado: (2022) -
Reassessment of Iron Biomarkers for Prediction of Dialysis Iron Overload: An MRI Study
por: Rostoker, Guy, et al.
Publicado: (2015)